Pfizer has gained FDA approval for Eucrisa, a new eczema treatment which could achieve peak annual sales of $2 billion a year. The drug is significant because it is the first non-steroidal therapy ...

Treatments for atopic dermatitis ... inhibitors (TCIs), phosphodiesterase inhibitors (Eucrisa), or janus kinase inhibitors (Opzelura)—for eczema treatment on thinner skin. They can help reduce ...